Co-Grafts in Dopamine-Depleted Primates: Preliminary Results and Theoretical Issues Related to Human Applications for Parkinson’s Disease

  • J. R. SladekJr.
  • J. D. Elsworth
  • R. H. Roth
  • B. C. Blanchard
  • J. R. Taylor
  • T. J. Collier
  • D. E. RedmondJr.
Part of the Altschul Symposia Series book series (ALSS, volume 3)

Transplantation of embryonic mesencephalon has been attempted in several hundred Parkinson’s disease patients worldwide. Initial reports support the role of these dopamine-producing grafts in ameliorating some of the signs and symptoms of the disease (Lindvall et al., 1989; Lindvall et al., 1990; Freed et al., 1992; Spencer et al., 1992; Widner et al., 1992). In particular, many patients 1) require less daily levodopa after grafting, 2) have a greater percentage of “on” time, and 3) show reduced dyskinesias. Nevertheless, considerable variation exists in the methodological approach followed by each group of clinical investigators, in part because it is difficult to perform experiments with human neural tissue that would provide unequivocal answers to technical questions about optimal survival parameters for the grafted tissue. For example, a study of the survival rate of grafted human dopamine neurons utilized the rat as a host (Brundin et al, 1988). This investigation found poor (i.e. 2-5%) survival of dopamine neurons, which may be influenced by several factors including the relatively small size of the rat brain. Perhaps, there is insufficient room to permit survival of great numbers of these proportionally larger human neurons in the confines of the rat striatum. Moreover, the role, if any, played by immunosuppression is unclear. As a consequence of this low survival, some clinical experiments have utilized mesencephalic tissue from several embryos in attempts to increase the total number of viable dopamine neurons, but this results in a considerably larger number of grafted non-dopaminergic neurons and the role of these presumably “silent” neurons is unknown. Since these grafts contain substantial numbers of neuroblasts and progenitor cells of the ventral mesencephalon, they presumably could be replete with neuronal and glial representatives of the mesencephalic reticular formation, the red nucleus, the ventral tegmentum, the oculomotor and trochlear nuclei, the proprioceptive nucleus of the trigeminal complex, serotonergic neurons of the dorsal raphe and many others for example. Since we are unaware of the influence that these neurons may exert on the host brain, it might be prudent to limit the potential contribution of this non-dopaminergic constituent of ventral mesencephalic grafts. This suggests that attention should be paid to mechanisms for enhancing the yield of grafted dopamine neurons.

Keywords

Dopamine Tyrosine Norepinephrine Neurol Catecholamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Annett LE, Martel FL, Rogers DC, Ridley RM, Baker HF and Dunnett SB (1993): Behavioural assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 125: 228–246.CrossRefGoogle Scholar
  2. Bakay RAE, Fiandaca MS, Barrow DL, Schiff A and Collins DC (1985): Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced parkinsonian-like syndrome in primates. Appl Neurophys 48: 358–361.Google Scholar
  3. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Kopin IJ and Oldfield EH (1991): Fetal nondopaminergic neural implants in parkinsonian primates. J Neurosurg 74: 97– 104.PubMedCrossRefGoogle Scholar
  4. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Porrino L, Di Porzio U, London WT, Kopin IJ and Oldfield EH (1990): The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. J Neurosurg 72: 231–244.PubMedCrossRefGoogle Scholar
  5. Bohn MC, Cupit L, Marciano F and Gash DM (1987): Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913–916.PubMedCrossRefGoogle Scholar
  6. Brundin P, Strecker RE, Widner H, Clarke DJ, Nilsson OG, Astedt B, Lindvall O and Björklund A (1988): Human fetal dopamine neurons grafted in a rat model of Parkinson’s disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res 70: 192–208.PubMedGoogle Scholar
  7. De Beaurepaire R and Freed WJ (1987): Embryonic substantia nigra grafts innervate embryonic striatal co-grafts in preference to mature host striatum. Exper Neurol 95: 448–454.CrossRefGoogle Scholar
  8. Dunnett SB, Rogers DC and Richards SJ (1989): Nigrostriatal reconstruction after 6­OHDA lesions in rats: Combination of dopamine-rich nigral grafts and nigrostriatal “bridge” grafts. Exper Brain Res 75: 523–535.Google Scholar
  9. Elsworth JD, Deutch AY, Redmond DE Jr, Taylor JR, Sladek JR Jr and Roth RH (1989): Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine­treated primates:bichemical changes in striatal regions. Neuroscience 33: 323–331PubMedCrossRefGoogle Scholar
  10. Elsworth JD, Sladek Jr, JR, Redmond Jr, DE, Taylor JR, Collier TJ and Roth RH (1994): Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum, or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys. Neurosci (submitted).Google Scholar
  11. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, Ramig LO, Thompson L, Mazziotta JC, Huang SC, Grafton ST, Brooks D, Sawle G, Schroter G and Ansari AA (1992): Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. New Eng J Med 327: 1549–55.PubMedCrossRefGoogle Scholar
  12. Hemmendinger LM, Garber BB, Hoffman PC and Heller A (1981): Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc Natl Acad Sci USA 78: 1264–1268.PubMedCrossRefGoogle Scholar
  13. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leender K, Rothwell JC, Frackowiak R, Marsden CD, Johnels B, Steg G, Freedman R, Hoffer BJ, Seiger A, Bygdeman M, Strömberg I and Olson L (1989): Human fetal dopamine neurons grafted into the striatum in two patients with severe parkinson’s disease. Arch Neurol 46: 615–631.PubMedCrossRefGoogle Scholar
  14. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD and Björklund A (1990): Grafts of fetal dopamine neurons survive and improve motor function in parkinson’s disease. Science 247: 574–577.PubMedCrossRefGoogle Scholar
  15. Olson L, Strömberg I, Bygdeman M, Granholm A-Ch, Hoffer B, Freedman R and Seiger A (1987): Human fetal tissues grafted to rodent hosts: structural and functional observations of brain, adrenal and heart tissues in oculo. Exp Brain Res 67: 163-­178.PubMedCrossRefGoogle Scholar
  16. Prochiantz A, Di Porzio I, Dato A, Berger B and Glowinski J (1979): In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci USA 76: 5387–5391.PubMedCrossRefGoogle Scholar
  17. Sladek JR Jr, Collier TJ, Haber SN, Roth RH and Redmond DE Jr (1986): Survival and growth of fetal catecholamine neurons tranplanted into primate brain. Brain Res Bull 17: 809–818.PubMedCrossRefGoogle Scholar
  18. Sladek JR Jr, Redmond DE Jr, Collier TJ, Haber SN, Elsworth JD, Deutsch AY and Roth RH (1987): Transplantation of fetal dopamine neurons into primate brain reverses MPTP-induced parkinsonism. Prog Brain Res 71: 309–322PubMedCrossRefGoogle Scholar
  19. Sladek JR Jr, Redmond DE Jr, Collier TJ, Blount JP, Elsworth JD, Taylor JR and Roth RH (1988): Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 78: 497–506.PubMedCrossRefGoogle Scholar
  20. Sladek JR Jr, Collier TJ, Elsworth JD, Taylor JR, Roth RH and Redmond DE Jr (1993a): Can graft-derived neurotrophic activity be used to direct axional outgrowth of grafted dopamine neurons for circuit reconstruction in primates? Exp Neurol 124: 134–139.CrossRefGoogle Scholar
  21. Sladek JR Jr, Elsworth JD, Roth RH, Evans LE, Collier TJ, Cooper SJ, Taylor JR and Redmond DE Jr (1993b): Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in non-human primates. Exp Neurol 122: 16–27.CrossRefGoogle Scholar
  22. Sladek JR Jr, Blanchard BC, Collier TC, Elsworth JD, Taylor JR, Roth RH and Redmond DE Jr (1994): Optimal survival of grafted mesencephalic dopamine (DA) neurons is attained from tissue taken during neurogenesis of the substantia nigra in non­human primate. Soc Neurosci Abstr 20: 1328.Google Scholar
  23. Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, Sass KJ, Elsworth JD, Kier LE, Makuch R, Hoffer PB and Redmond DE Jr (1992): Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of Parkinsonian patients: functional effects for 18 months. New Eng J Med 327: 1541–1548.PubMedCrossRefGoogle Scholar
  24. Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Collier TJ and Redmond DE Jr (1991) Fetal grafting of substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp Brain Res 85: 335–348.PubMedCrossRefGoogle Scholar
  25. Taylor JR, Elsworth JD, Sladek JR Jr, Collier TJ, Roth RH and Redmond DE Jr (1994): Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. Cell Transplant, in press.Google Scholar
  26. Wechsler RT, Sladek JR Jr, Blanchard BC, Collier TJ, Elsworth JD, Taylor JR, Roth RH and Redmond DE Jr (1993): Sprouting of host dopamine fibers in response to grafts of embryonic striatum in adult African green monkeys. Soc Neurosci Abstr 19: 1509.Google Scholar
  27. Wechsler RT, Blanchard BC, Collier TJ, Elsworth JD, Taylor JR, Roth RH, Redmond DE Jr and Sladek JR Jr (1994): Host striatum projects fibers into transplanted fetal mesencephalon in a parkinsonian primate model. Soc Neurosci Abstr 20: 1328.Google Scholar
  28. Wictorin K, Brundin P, Gustavii B, Lindvall O and Björklund A (1990): Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature 347: 556–558.PubMedCrossRefGoogle Scholar
  29. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O and Langston JW (1992): Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New Eng J Med 327: 1557–1563.CrossRefGoogle Scholar
  30. Yurek DM, Collier TJ and Sladek JR Jr (1990): Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp Neurol 109: 191–199.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • J. R. SladekJr.
  • J. D. Elsworth
  • R. H. Roth
    • 3
  • B. C. Blanchard
    • 1
  • J. R. Taylor
    • 3
  • T. J. Collier
    • 2
  • D. E. RedmondJr.
    • 3
  1. 1.Department of NeuroscienceChicago Medical SchoolChicagoUSA
  2. 2.Departments of Pharmacology and PsychiatryYale School of MedicineNew HavenUSA
  3. 3.Department of Neurological SciencesRush College of MedicineChicagoUSA

Personalised recommendations